Pharmaceuticals

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

The Pharma and Biotech market was relatively buoyant in March with 49% of share prices in the coverage universe increasing for the month. There was some...

Below, we take a look at four stocks that have been amongst the best performers in the first two months of the new year.

There was some significant news flow in November 2023 which saw the shares of a number of pharma and biotech companies rally strongly. The share price of three...

We weigh the latest blockbuster weight-loss drugs against pharmaceuticals (and others) that have gone before

Breakthroughs in obesity drugs look extraordinarily profitable for 2 stocks. But, with improvements, a raft of sectors might be affected.

It was a tough month for the Pharma & Biotech coverage universe with 73.2% of share prices for companies in the universe either flat or negative for the month of...

In this edition of the Movers & Shakers for Pharma & Biotech, we highlight 5 stocks that were on the move in September. Biotron Limited (ASX: BIT) Bitron shares were...

With usage of anti-obesogenic drugs on the rise, the end of obesity comes winners and losers. And investment opportunties

Below we take a look at 5 Australian Pharma & Biotech stocks that experienced significant share price moves, both positive and negative, through the month of August....

Platinum's Dr Bianca Ogden shares the big tech trends transforming healthcare and companies she likes

The below takes a look at six ASX pharma and biotech stocks that experienced significant share price moves through the month as important news flow came through. 1)...

Despite some negative performers, there were still a number of companies that experienced significant share price gains.

Australian biotech and pharma had a number of key results in May with several stocks rallying. I look at 6 companies on the move.

April continued to be a strong month for Australian pharma and biotech companies with a number of successful trials, and contracts, with potential for global...

March witnessed plenty of movers and shakers in the biotech industry, with a number of key successes in trials, and others showing strong results, leading strong...

The best opportunities are found when you don't follow the herd.

Welcome to the first edition of the IIR Movers & Shakers report for Pharma & Biotech. Each month, we will be looking at those stocks that experience significant share...

Can you do well by doing good?"As always, Cipla will follow a compassionate and humanitarian approach to healthcare that goes beyond the pursuit of profit. Access to...

The US tax year is ruled off at the end of December. Typically, there is tax loss selling in US stocks in the lead up to the end of the year, followed by a relief to...